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through long term psychotherapeutic treatment or in some other 
way recover completely from the disorder. How could an illness be 
degenerative if it was possible to recover from it?
During the 1980 and 1990s several longitudinal studies of neu-
rocognitive functioning in patients with schizophrenia began to 
emerge. These studies showed no evidence of decline in function 
over time. This was taken to indicate that there is no ongoing degen-
erative process in the brain, at least not after the onset of illness 
(Rund, 1998). Instead, a neurodevelopmental model emerged as 
the dominant explanatory framework for schizophrenia. According 
to this model normal brain development is disturbed by genetic or 
environmental factors in patients with schizophrenia. The model 
is supported by ﬁ  ndings like higher prevalence of obstetric com-
plications, minor physical anomalies, and neurological soft signs 
among people who later develop schizophrenia; as well as brain 
morphology ﬁ  ndings that show smaller brain volumes even before 
the emergence of psychotic symptoms. The neurodevelopmental 
hypothesis was put forward as an alternative to the neurodegenera-
tive hypothesis, although the two models do not stand in opposition 
to each other.
However, a few years ago the hypothesis of schizophrenia as a 
degenerative disorder re-emerged. This was primarily based on 
several new longitudinal magnetic resonance imaging (MRI) stud-
ies that showed substantial increases in the brains cavities (see 
next section), and corresponding excessive shrinkage of vital brain 
tissue, during the ﬁ  rst years after the onset of illness. These studies 
INTRODUCTION
Schizophrenia is a complex biological and behavioural disorder 
which manifests itself in neurocognitive dysfunctions. The  question 
of whether these key characteristics of the disorder are due to 
schizophrenia being a degenerative disorder has been discussed 
for more than 100 years.
Before we go into the main theme of this paper, a clariﬁ  cation of 
a central concept might be necessary, namely degeneration. What 
characterizes a neurodegenerative process? The main issue is that 
brain tissue is destroyed. This usually includes cytopathology as 
well as neuronal and synaptic loss followed by gliosis, i.e. scar tis-
sue development of the brain. It can also include programmed cell 
death, such as apoptosis, which does not lead to any scar tissue. 
Further, probably loss of isolated nerve cells may occur without 
gliosis. A degenerative process is the basis for most states of demen-
tia. However, we must also be aware of the fact that a decrease in 
the brain volume (grey matter) occurs in healthy people, starting 
at the age of 15–20 years (Rapoport et al., 1999; Hulshoff Pol and 
Kahn, 2008). An important emerging research area is the role of 
glia cells in the regulation of neurodegeneration. A comprehensive 
treatment of this topic is beyond the scope of this paper. A review 
of this topic is to be found in Müller and Schwarz (2007).
Kraepelin (1919) was clearly of the opinion that schizophrenia is 
a degenerative disorder (dementia praecox). This view held stance 
until the middle of the last century. At that time some reports 
began to emerge that patients with schizophrenia could be cured 
Is there a degenerative process going on in the brain of people 
with schizophrenia?†
Bjørn Rishovd Rund 1,2*
1  Vestre Viken Hospital Trust, Rud, Norway
2  Department of Psychology, University of Oslo, Oslo, Norway
Schizophrenia is a biological and behavioural disorder which manifests itself in neurocognitive 
dysfunctions. The question of whether these key characteristics of the disorder are due to 
schizophrenia being a degenerative disorder has been discussed for more than 100 years. 
Neuropsychological data indicate that neurocognitive functions are relatively stable over time 
after illness onset. Several studies show that there is a decline in neurocognitive functioning 
prior to and in connection with onset of illness. There is no convincing evidence, however, that 
there is a progressive neurodegenerative process after onset of illness. Morphological data, 
on the other hand, indicate a degenerative process. Several novel longitudinal studies indicate 
a rapid reduction of vital brain tissues after onset of illness. In this paper some ideas about 
compensatory reactions and Cognitive Reserve Theory is outlined as possible explanations of 
the recent magnetic resonance imaging studies that show structural changes in the brain after 
the onset of schizophrenia, at the same time as cognitive functioning does not become more 
impaired. Determining whether schizophrenia is a neurodegenerative illness with progressive 
structural changes in the brain after debut of the illness, or a neurodevelopmental disorder 
starting in early life, is of signiﬁ  cant importance for understanding the pathophysiology of the 
illness and its treatments.
Keywords: schizophrenia, neurocognition, degeneration, neurodevelopmental process, compensatory reactions
Edited by:
Kenneth Hugdahl, 
University of Bergen, Norway
Reviewed by:
Ole A. Andreassen, Ulleval University 
Hospital, Norway; University of Oslo, 
Norway
Thomas Dierks, University Hospital of 
Psychiatry, Switzerland
*Correspondence:
Bjørn Rishovd Rund, Vestre Viken 
Hospital Trust, Asker og Bærum 
Hospital, P .O. Box 83, Rud, Norway. 
e-mail: bjorn.rishovd.rund@sabhf.no
†This paper is based on an article 
published in Nordic Journal of 
Psychiatry, 2009, Volume 63(3), pp. 
196–201, by the same author and with 
the title “Is schizophrenia a 
neurodegenerative disorder?”Frontiers in Human Neuroscience  www.frontiersin.org  October 2009  | Volume 3  |  Article 36  |  2
Rund  Is schizophrenia a neurodegenerative disorder?
have led some to opine that the  neurodegenerative hypothesis may 
have been overshadowed by the ascendancy of the neurodevelop-
mental hypothesis (Weinberger and McClure, 2005).
WHAT DO WE KNOW ABOUT STRUCTURAL CHANGES IN THE 
BRAIN OF PATIENTS WITH SCHIZOPHRENIA?
First of all, we have clear empirical support to state that there are 
changes occurring in the brains of patients with schizophrenia 
(Shenton et al., 2001; Harrison and Lewis, 2003; Weinberger and 
Marenco, 2003; Weinberger and McClure, 2005). The most robust 
ﬁ  ndings seem to be that patients with schizophrenia have:
a.  Larger ventricles than healthy controls. An increase in the late-
ral ventricle was found in 80% of the studies, while an enlarged 
third ventricle was found in 73% of the studies (Weinberger 
and Marenco, 2003). Seen together, 30 studies have found that 
patients with schizophrenia had 26% larger ventricles than 
healthy controls.
b.  The volume of the frontal lobes is reduced compared to healthy 
controls. This was found in 59% of the studies. Parietal- and 
occipital lobe-abnormalities have also been found in several 
studies (Niznikiewicz et al., 2003).
c.  There is a reduction in the volume of the temporal lobes, 
amongst other areas in the medial temporal lobe, which inclu-
des the amygdala–hippocampal complex and the neocortical 
temporal lobe. Temporal lobe reduction was found in 74% of 
the studies (Shenton et al., 2001).
However, it is primarily the fact that these changes in the brain 
seem to progress at rapid speed after the patient has become ill, at 
least the ﬁ  rst years after the onset of illness, which has strengthened 
the hypothesis of an ongoing degenerative process. This has been 
shown in recent longitudinal studies including several ﬁ  rst episode 
studies. In most of these studies structural brain changes have been 
found already at the time of onset of the psychosis. Pantelis and 
colleagues (Pantelis et al., 2003) found structural brain changes 
already prior to illness onset in high risk individuals. They found 
reduced grey matter in individuals who later developed a psychotic 
illness compared to those who did not. Gur et al. (1998) have also 
found clear indications that changes in the brain take place before 
the clinical symptoms emerge. While the early longitudinal studies 
did not indicate any progressive deterioration of the brain early in 
the illness (Weinberger and Marenco, 2003), the pattern is different 
in many of the more recent studies. Several of these studies showed 
dramatic structural changes over a relatively short time period:
–  Chakos et al. (2005) showed that patients with schizophrenia 
had less hippocampal volume than age matched healthy con-
trols and that the volume reduction was larger in older, than in 
younger patients.
–  Jacobsen et al. (1998) documented a 7% reduction of the hip-
pocampus per year.
–  Rapoport et al. (1997) reported a 7% reduction of the thala-
mus per year in adolescents with schizophrenia. Further they 
found a 10% increase in ventricular volume per year. In a 
later publication the same research group (Rapoport et al., 
1999)   reported a signiﬁ  cant reduction in grey matter in fron-
tal and parietal areas in these adolescent patients over a 3- to 
5-year period.
–  Mathalon et al. (2001) showed that the left lateral ventricle 
increased by 13% a year, or a doubling of the size within an 
8-year period.
–  DeLisi et al. (1998) identiﬁ  ed a clear reduction in hemisphe-
ric volume in 50 patients with ﬁ  rst episode schizophrenia fol-
lowed over a 4-year period.
–  Sporn et  al. (2003) found a substantial loss of grey mat-
ter through the teenage years in patients with early onset 
schizophrenia.
–  Kasai et al. (2003) found a 9.6% progressive reduction in grey 
matter in the upper left temporal gyrus over a period of 1.5-year 
after the ﬁ  rst hospitalization in patients with schizophrenia.
–  Lawrie et  al. (2002) showed a reduction in temporal lobe 
volume over a 2-year period in individuals at high risk who 
developed psychotic symptoms during this period.
–  James et al. (2002) investigated early onset patients with schi-
zophrenia and found enlarged lateral and third ventricle, 
in addition to a reduction in the left part of the amygdala. 
However, these researchers did not ﬁ  nd further deterioration 
over a 3-year period.
–  Cahn et al. (2002) found that the whole brain grey matter 
decreased during a 1-year follow-up of ﬁ  rst-episode patients 
with schizophrenia.
–  Ho et al. (2003) carried out a 5-year follow-up study of ﬁ  rst-
episode schizophrenia patients and found that the frontal 
white matter decreased.
–  Jacob et al. (2005) followed the same prodromal cases as Lawrie 
et al. (2002) over another 3 years and conﬁ  rmed their ﬁ  ndings.
–  Whitford et al. (2006) found grey matter reductions in ﬁ  rst-
episode patients with schizophrenia that were followed-up 2–3 
years.
Taken together these studies indicate fairly comprehensive, multi 
focal structural changes in the brain over time in patients with 
ﬁ  rst episode psychosis. Progressive volume loss seems most pro-
nounced in the frontal and temporal areas. Progressive brain tissue 
loss in schizophrenia is, during a 20-year time period, found to be 
approximately twice that found in healthy people due to normal 
ageing (Hulshoff Pol and Kahn, 2008).
Another issue supporting a neurodegenerative hypothesis can be 
found in a study by Harvey et al. (1996). They found that in elderly 
patients with schizophrenia (above 65 years) there is a further reduc-
tion of neurocognitive functions beyond what would be expected 
from ageing. These results are based on a large patient sample. The 
ﬁ  ndings of Harvey et al. (1996) may lead to speculation as to whether 
schizophrenia in some way makes the person particularly sensitive to 
the development of dementia in old age, or whether the brain in this 
group of patients is more sensitive to neurocognitive impairments 
as a response to normal age-related neurodegeneration (2003).
WHAT DO THE NEUROPSYCHOLOGICAL LONGITUDINAL 
STUDIES OF PATIENTS WITH SCHIZOPHRENIA SHOW?
The strongest argument against schizophrenia being a neurodegen-
erative disorder is the many longitudinal studies of neurocognitive 
functions that show that there is no worsening after the onset of Frontiers in Human Neuroscience  www.frontiersin.org  October 2009  | Volume 3  |  Article 36  |  3
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illness. Rather in general there seems to be some improvement in 
neurocognitive functioning, at least during the ﬁ  rst period after 
the patients have gone into remission (Rund et al., 2006). It seems 
unlikely that a person can perform as well or better on various 
neuropsychological tests over time, if there is a simultaneously 
ongoing structural degeneration of the brain.
In 1998 Rund summarized the results of the 14 existing lon-
gitudinal studies of neurocognitive functioning in patients with 
schizophrenia (Rund, 1998). Only studies that had a follow-up 
time of at least 1 year were included in the analysis. It was con-
cluded that after the onset of illness neurocognitive functioning 
is relatively stable over time. Kurtz (2004) have updated Rund’s 
analysis with eight new longitudinal studies that have been pub-
lished since 1997. Kurtz et al’s results conﬁ  rm the conclusion of 
Rund (Rund, 1998).
After this review article was published, Andreasen et al. (2005) 
have published results from a 9-year follow-up study. They show 
the same improvement in neurocognitive functioning that has been 
found in a number of studies the ﬁ  rst years after the onset of ill-
ness. However, after 5 years the upward curve ﬂ  attens out, and after 
9 years the patients perform at the same level as they did at the 
ﬁ  rst assessment.
Two studies with a 10-year follow-up time (Stirling et al., 2003; 
Hoff et al., 2005) show the same trend. Hoff et al. (2005) found 
no further reduction in neurocognitive functions over the ﬁ  rst 
10 years in patients that were assessed the ﬁ  rst time at the onset 
of illness. However, they showed less improvement after 10 years 
than healthy controls on speciﬁ  c functions when controlling for 
differences between the groups at the ﬁ  rst assessment. Hoff and 
colleagues concluded that patients remain relatively stable with 
regard to their level of neurocognitive functioning, at least through 
the ﬁ  rst 10 years after the onset of illness.
Finally, these ﬁ  nding are conﬁ  rmed and strengthened by a recent 
report from Øie et al. (2008). She has followed a group of early-
onset schizophrenia over a 13-year period; a longer follow-up than 
in any other study. The main ﬁ  nding in this study is a signiﬁ  cant 
decline in verbal memory and learning, and an arrest; i.e. lack of 
improvement, in attention and processing speed.
Beyond this general pattern of stability over the ﬁ  rst years after 
illness onset, there is probably a certain ﬂ  uctuation in level of 
functioning, particularly in functions that are state related (i.e. 
inﬂ  uenced by clinical state). In one study Rund et al. (1997) inves-
tigated 15 patients with schizophrenia with a battery consisting 
of 10 neuropsychological tests in two distinct different phases; an 
acute phase and a remission phase. We found a clear tendency 
that patients performed better when they were in remission. This 
may indicate that the psychotic experiences/symptoms themselves 
make it more difﬁ  cult to concentrate on the test, something which 
is necessary to perform well. It is difﬁ  cult to know whether it is the 
fact that the psychotic symptoms disappear that makes the patient 
also perform better on neuropsychological tests, or whether the 
improvement is caused by other factors, such as for instance the 
direct chemical effect of medication.
What else, in addition to the longitudinal studies of neurocogni-
tive functioning, goes against schizophrenia being a degenerative 
disorder? Several biological “markers” appear to do so. First of all, 
there is no evidence of gliosis in schizophrenia (Woods, 1998), 
which is a sign of degeneration (see Section “Introduction”). Also, 
in post mortem studies there is no consistent evidence of degener-
ated neurons, cellular changes, loss of cell embryos, or molecular 
changes (Weinberger and Marenco, 2003).
A third argument against schizophrenia being a degenerative dis-
order is the fact that many patients show clinical improvement over 
time. In several of the longitudinal MR-studies (Rapoport et al., 
1997; DeLisi et al., 1998; Gur et al., 1998; Jacobsen et al., 1998) the 
patients showed clinical improvement during the same time period 
that large structural changes took place in the brain. As Weinberger 
and Marenco (2003) pointed out, clinical improvement is hardly 
what one would expect as a result of progressive loss of brain tis-
sue. This is, however, a more likely combination than performing 
as well on neuropsychological tests over time, while at the same 
time loosing brain tissue. Actually, Sporn et al. (2003) found that 
a greater degree of clinical improvement was signiﬁ  cantly related 
to a reduction in grey matter.
WHEN DO THE COGNITIVE IMPAIRMENTS EMERGE?
There is no doubt that neurocognitive impairments are evident at 
the onset of illness in most patients who develop schizophrenia. 
However, we must also be aware that 35–40% of the patients do not 
have a signiﬁ  cant impairment in neurocognitive functioning (Rund 
et al., 2006); i.e. they function within what must be characterized as 
the normal range (some healthy controls also function below aver-
age). Nevertheless, patients functioning within the normal range 
may have had a reduction in neurocognitive functioning after they 
became ill. Also several studies of high risk groups have found that 
these individuals show signs of neurocognitive deﬁ  cits many years 
prior to the onset of illness (Jones et al., 1994; Cornblatt et al., 1999; 
Cannon et al., 2000; Fuller et al., 2002; Niendam et al., 2003; Ang 
and Tan, 2004). Moreover, several prodromal studies indicate that 
the neurocognitive impairments evident after the psychotic break-
through are also evident prior to the onset of illness (Caspi et al., 
2003; Gschwandtner et al., 2003; Wood et al., 2003; Hawkins et al., 
2004; Brewer et al., 2005). Probably there is a further reduction in 
neurocognitive functioning just prior to the ﬁ  rst psychotic episode 
(Caspi et al., 2003). A preliminary conclusion is that precursors to 
the cognitive deﬁ  cits are evident relatively early, that these develop 
gradually and that they are found in corresponding form and approx-
imately the same degree in the prodromal phase, as in remission. 
The psychotic experiences or symptoms exacerbate the neurocogni-
tive deﬁ  cits somewhat during the acute phase. Such a development 
with an early insult in the neural development that remains for the 
duration of life, but that does not get worse over time, may best be 
characterized as a static encephalopathy (Rund, 1998).
HOW CAN THE CONTRADICTORY FINDINGS FROM 
MORPHOLOGICAL AND NEUROPSYCHOLOGICAL STUDIES BE 
EXPLAINED?
There is no doubt that there is a “deterioration” of most neuro-
cognitive functions in patients who develop schizophrenia. But 
much of this seems to occur prior to the onset of illness. We also 
have reason to believe that this neurocognitive deterioration to 
some degree runs parallel with structural changes in the brain. If 
one chooses to use the term neurodegeneration about what hap-
pens prior to the onset of illness, there is evidence suggesting that Frontiers in Human Neuroscience  www.frontiersin.org  October 2009  | Volume 3  |  Article 36  |  4
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resonance imaging studies of   bipolar 
disorder and schizophrenia: a 
meta-analysis. Br. J. Psychiatry 195, 
194–201.
Brewer, W. J., Francey, S. M., Wood, S. J., 
Jackson, H. J., Pantelis, C., Phillips, L. J., 
Yung, A. R., Anderson, V. A., and 
as in the high risk group that developed psychotic symptoms. 
It is also likely that the brain compensates for some of the loss 
that occurs in nerve cells or neuropil.
Animal studies indicate that damage to the brain may illicit 
compensatory reactions such as synaptic growth. It is also possible 
that new cells may develop in the human brain. Stern (2002) sug-
gests that the brain actively attempts to cope with, or compensate 
for, pathology. The idea of reserve against brain damage stems 
from the repeated observation that there does not appear to be 
a direct relationship between degree of brain damage and the 
clinical manifestation of that damage. Cognitive Reserve Theory 
explains why individuals evidence different neuropsychologi-
cal deﬁ  cits following the same neurological damage. Cognitive 
reserve may be based on more efﬁ  cient utilization of brain net-
works or of enhanced ability to recruit alternate brain networks 
as needed.
There are several possible alternative models that may explain 
the brain changes occurring after the onset of illness: It could be 
degeneration occurs with varying degrees of compensation or it 
could be that there are regressive processes that are undetectable 
in macroscopic investigations of the brain. It is also possible that 
there is a reorganization of synaptic connections without any form 
of degeneration or regression. Further, it could be that the brain 
more efﬁ  ciently utilizes brain networks or enhances the ability to 
recruit alternative brain networks as needed, as Cognitive Reserve 
Theory suggests.
Still another possibility is that brain structural or volumetric 
changes affect certain sub-groups of patients more than others. 
A complicating matter could, however, be the heterogeneity of 
schizophrenia and individual variation regarding both functional 
and structural brain measures. In a recent meta-analysis of MR 
volumetric changes in schizophrenia and bipolar disorders, com-
pared to healthy controls (Arnone et al., 2009), it was found that 
schizophrenia patients differed from bipolar patients with more 
regional structural changes compared to global changes in bipolar 
disorder patients. Implicated regions were enlargement of the lat-
eral ventricles, pointing to frontal and temporal volumetric reduc-
tions in schizophrenia, and reduction of amygdale volume (Arnone 
et al., 2009). In addition, Kalus et al. (2004) reported reduction of 
hippocampal volume in patients with schizophrenia, which was 
related to alterations in white matter coherence between hippoc-
ampal sub-structures. In particular the hippocampal alterations 
could be related to the psychopathology of schizophrenia that could 
be more critical for sub-groups of patients with clearly deﬁ  ned 
cognitive impairments. It is therefore possible that previous stud-
ies of neurodegeneration have not paid enough attention to the 
symptomatic heterogeneity of the disorder, and that this could be 
related to brain structural changes over time, pointing to a possible 
degenerative process.
schizophrenia is a degenerative disorder. But this is not the regular 
use of the term degeneration, nor was this how Kraepelin used the 
term. With his “dementia praecox” term he was referring to the 
assumption that there is a progressive worsening of the condition 
after the onset of illness.
We cannot provide a deﬁ  nite answer as to whether schizophrenia 
is a degenerative disorder (in the sense of a progressive degenerative 
state after the onset of illness). Longitudinal studies of neurocogni-
tive functioning provide a relatively consistent indication that the 
impairment does not progressively worsen the ﬁ  rst years after the 
onset of illness. However, some longitudinal studies with a very long 
follow-up period indicate that there is a certain decline after many 
years of illness. This may be due to medication or other biologi-
cal effects. The decline may also be caused by under-  stimulation 
from the environment. (Such under-stimulation may also to a cer-
tain degree explain the structural changes evident in the brains of 
patients with schizophrenia.) In essence, we need to realize that the 
morphological data to a great extent are inconsistent. There are no 
two studies that have found the exact same structural changes in 
this patient group (Weinberger and McClure, 2005).
How can we then explain more recent MRI studies that show 
clear cut structural changes in the brain after the onset of illness, 
at the same time as neurocognitive functioning does not become 
more impaired? Two issues can be pointed out:
   The ﬁ  rst issue may be what Lieberman (1999) amongst others 
has suggested, i.e. that there may be two ongoing pathogenic 
processes in schizophrenia; one neurodevelopmental process 
and a limited neurodegenerative or neuroprogressive process. 
McGlashan and Hoffman (2000) suggest that such neuropro-
gressive processes are a developmentally determined reduction 
in the connections between cortical synapses. (If we empha-
size the fact that post mortem studies ﬁ  rst and foremost show 
loss in neuropil and not in nerve cells in the cortex in patients 
with schizophrenia, the term neuroprogressive is more ade-
quate than neurodegenerative). In Gur et  al.’s (1998) study 
for instance, they only identiﬁ  ed a sub-group of patients that 
showed progressive structural change after the onset of illness. 
Thus, it is possible that there are at least two types of schi-
zophrenia; one with a good prognosis and one with a poorer 
prognosis and a clearer biological basis. This would mean a 
return to a hypothesis which has been of great interest throu-
ghout the history of schizophrenia research (see, for instance, 
Murray et al., 1992).
  A second issue concerns the plasticity in the human 
brain. DeLisi et al. (1998) have for instance showed that the 
size of the ventricles may alternatively increase, decrease, then 
increase again over such short time periods as months. In the 
previously referred study by Lawrie et al. (2002), they found 
the same reduction in ventricular volume in healthy controls 
REFERENCES
Andreasen, N. C., Moser, D. J., 
O’Leary, D. S., and Ho, B.-C. (2005). 
Longitudinal changes in neurocog-
nition during ﬁ  rst decade of schizo-
phrenia illness. Schizophr. Bull. 31, 
348.
Ang, Y. G., and Tan, H. Y. (2004). Academic 
deterioration prior to first episode 
schizophrenia in young Singaporean 
males. Psychiatry Res. 121, 303–307.
Arnone, D., Cavanagh, J., Gerber, D., 
Lawrie, S. M., Ebmaier, K. P., and 
Mackintosh, A. M. (2009). Magnetic 
McGorry, P. D. (2005). Memory 
impairments identiﬁ  ed in people at 
ultra-high risk for psychosis who later 
develop ﬁ  rst-episode psychosis. Am. 
J. Psychiatry 162, 71–78.
Cahn, W., Hulshoff Pol, H. E., Lems, E. B., 
van Haren, N. E., Schnack, H. G., van Frontiers in Human Neuroscience  www.frontiersin.org  October 2009  | Volume 3  |  Article 36  |  5
Rund  Is schizophrenia a neurodegenerative disorder?
Pantelis, C., Velakoulis, D., McGorry, P. D., 
Wood, S. J., Suckling, J., Phillips, L. J., 
Yung, A. R., Bullmore, E. T, 
Brewer, W., Soulsby, B., Desmond, P., 
and McGuire,  P. K. (2003). 
Neuroanatomical abnormalities 
before and after onset of psychosis: a 
cross-sectional and longitudinal MRI 
comparison. Lancet 361, 281–288.
Rapoport, J. L., Giedd, J., Kumra, S., 
Jacobsen, L., Smith, A., Lee, P., 
Nelson, J., and Hamburger, S. (1997). 
Childhood-onset schizophrenia. 
Progressive ventricular change during 
adolescence. Arch. Gen. Psychiatry 54, 
897–903.
Rapoport, J. L., Giedd, J. N., Blumenthal, J., 
Hamburger, S., Jeffries, N., 
Fernandez, T., Nicolson, R., Bedwell, J., 
Lenane, M., Zijdenbos, A., Paus, T., 
and Evans, A. (1999). Progressive 
cortical change during adolescence 
in childhood-onset schizophrenia. 
A longitudinal magnetic resonance 
imaging study. Arch. Gen. Psychiatry 
56, 649–654.
Rund, B. R. (1998). A review of longitu-
dinal studies of cognitive functions in 
schizophrenia patients. Schizophr. Bull. 
24, 425–435.
Rund, B. R., Landro, N. I., and Orbeck, A. L. 
(1997). Stability in cognitive dys-
functions in schizophrenic patients. 
Psychiatry Res. 69, 131–141.
Rund, B. R., Sundet, K., Asbjørnsen, A., 
Egeland, J., Landrø, N. I., Lund, A., 
Roness, A., Stordal, K. I., and 
Hugdahl, K. (2006). Contrasts in neu-
ropsychological test proﬁ  les between 
patients with schizophrenia and recur-
rent non-psychotic major depression. 
Acta Psychiatr. Scand. 113, 350–359.
Shenton, M. E., Dickey, C. C., Frumin, M., 
and McCarley, R. W. (2001). A review 
of MRI findings in schizophrenia. 
Schizophr. Res. 49, 1–52.
Sporn, A. L., Greenstein, D. K., Gogtay, N., 
Jeffries, N. O., Lenane, M., Gochman, P., 
Clasen, L. S., Blumenthal, J., Giedd, J. N., 
and Rapoport, J. L. (2003). Progressive 
brain volume loss during adolescence 
in childhood-onset schizophrenia. Am. 
J. Psychiatry 160, 2181–2189.
Stern, Y. (2002). What is cognitive reserve? 
Theory and research application of the 
reserve concept. J. Int. Neuropsychol. 
Soc. 8, 448–460.
Stirling, J., White, C., Lewis, S., Hopkins, R., 
Tantam, D., Huddy, A., and Montague, 
L. (2003). Neurocognitive function and 
outcome in ﬁ  rst-episode schizophre-
nia: a 10-year follow-up of an epide-
miological cohort. Schizophr. Res. 65, 
75–86.
Weinberger, D. R., and McClure, R. K. 
(2005). Neurotoxicity, neuroplas-
ticity, and magnetic imaging mor-
phometry. Arch. Gen. Psychiatry 59, 
553–558.
in schizophrenia. Neurreport 15, 
867–871.
Kasai, K., Shenton, M. E., Salisbury, D. F., 
Hirayasu, Y., Lee, C. U., Ciszewski, A. A., 
Yurgelun-Todd, D., Kikinis, R., 
Jolesz, F. A., and McCarley, R. W. (2003). 
Progressive decrease of left superior 
temporal gyrus gray matter volume in 
patients with ﬁ  rst-episode schizophre-
nia. Am. J. Psychiatry 160, 156–164.
Kraepelin, E. (1919). Dementia Praecox 
and Paraphrenia. Edinburgh, E and S 
Livingstone.
Kurtz, M. M. (2004). Neurocognitive 
impairment across lifespan in schizo-
phrenia: an update. Schizophr. Res. 74, 
15–26.
Lawrie, S. M., Whalley, H. C., Abukmeil, 
S. S., Kestelman, J. N., Miller, P., Best, 
J. J., Owens, D. G., and Johnstone, E. C. 
(2002). Temporal lobe volume changes 
in people at high risk of schizophre-
nia with psychotic symptoms. Br. J. 
Psychiatry 181, 138–143.
Lieberman, J. A. (1999). Pathophysiologic 
mechanisms in the pathogenesis and 
clinical course of schizophrenia. 
J. Clin.  Psychiatry 60(Suppl. 12), 
9–12.
Mathalon, D. H., Sullivan, E. V., Lim, K. O., 
and Pfefferbaum, A. (2001). Progressive 
brain volume changes and the clini-
cal course of schizophrenia in men: 
a longitudinal magnetic resonance 
imaging study. Arch. Gen. Psychiatry 
58, 148–157.
McGlashan, T. H., and Hoffman, R. E. 
(2000). Schizophrenia as a disorder 
of developmentally reduced synaptic 
connectivity. Arch. Gen. Psychiatry 57, 
637–648.
Müller, N., and Schwarz, M. J. (2007). The 
immunological basis of glutamatergic 
disturbance in schizophrenia: towards 
an integrated view. J. Neural Transm. 
Suppl. 72, 269–280.
Murray, R. M., O’Callaghan, E., Castle, D. 
J., and Lewis, S. W. (1992). A neurode-
velopmental approach to the classiﬁ  -
cation of schizophrenia. Schizophr. 
Bull. 18, 319–332.
Niendam, T. A., Bearden, C. E., 
Rosso, I. M., Sanchez, L. E., Hadley, T., 
Nuechterlein, K. H., and Cannon, T. D. 
(2003). A prospective study of childhood 
neurocognitive functioning in schizo-
phrenic patients and their siblings. Am. 
J. Psychiatry 160, 2060–2062.
Niznikiewicz, M. A., Kubicki, M., and 
Shenton, M. E. (2003). Recent struc-
tural and functional imaging find-
ings in schizophrenia. Curr. Opin. 
Psychiatry 16, 123–148.
Øie, M., Sundet, K., and Rund, B. R. (2008). 
Neurocognitive decline in early-onset 
schizophrenia compared with ADHD 
and normal controls: evidence from 
a 13-year follow-up study. Schizophr. 
Bull. doi: 10.1093/scbul/sbn 127.
neurobehavioral measures. Arch. Gen. 
Psychiatry 55, 145–152.
Harrison, P. J., and Lewis, D. A. (2003). 
Neuropathology of schizophrenia. In 
Schizophrenia, 2nd Edn, S. R. Hirsch, 
and D. R. Weinberger, eds (London, 
Blackwell  Publishing), pp. 310–325.
Harvey, P. D., Lombardi, J., Leibman, M., 
White, L., Parrella, M., Powchik, P., 
and Davidson, M. (1996). Cognitive 
impairment and negative symptoms 
in geriatric chronic schizophrenic 
patients: a follow-up study. Schizophr. 
Res. 22, 223–231.
Hawkins, K. A., Addington, J., Keefe, 
R. S., Christensen, B., Perkins, D. O., 
Zipurksy, R., Woods, S. W., Miller, T. J., 
Narqueez, E., Breier, A., and McGlashan, 
T. H. (2004). Neuropsychological status 
of subjects at high risk for a ﬁ  rst epi-
sode of psychosis. Schizophr. Res. 67, 
115–122.
Ho, B. C., Andreasen, N. C., Nopoulos, P., 
Arndt, S., Magnotta, V., and Flaum, M. 
(2003). Progressive structural brain 
abnormalities and their relationship to 
clinical outcome; a longitudinal mag-
netic resonance imaging study early in 
schizophrenia. Arch. Gen. Psychiatry 
60, 585–594.
Hoff, A. L., Svetina, C., Shields, G., 
Stewart, J., and DeLisi, L. E. (2005). Ten 
year longitudinal study of neuropsy-
chological functioning subsequent 
to a first episode of schizophrenia. 
Schizophr. Res. 78, 27–34.
Hulshoff Pol, H. E., and Kahn, R. S. (2008). 
What happens after the ﬁ  rst episode? 
A review of progressive brain changes 
in chronically ill patients with schizo-
phrenia. Schizophr. Bull. 34, 354–366.
Jacob, D. E., Whalley, H. C., Johnstone, E. C., 
and Lawrie, S. M. (2005). Grey matter 
changes over time in high risk subjects 
developing schizophrenia. Neuroimage 
25, 1023–1030.
Jacobsen, L. K., Giedd, J. N., Castellanos, 
F. X., Vaituzis, A. C., Hamburger, S. 
D., Kumra, S., Lenane, M. C., and 
Rapoport, J. L. (1998). Progressive 
reduction of temporal lobe structures 
in childhood-onset schizophrenia. 
Am. J. Psychiatry 155, 678–685.
James, A. C., Javaloyes, A., James, S., and 
Smith, D. M. (2002). Evidence for 
non-progressive changes in adoles-
cent-onset schizophrenia: follow-up 
magnetic resonance imaging study. Br. 
J. Psychiatry 180, 339–344.
Jones, P., Rodgers, B., Murray, R., and 
Marmot, M. (1994). Child develop-
ment risk factors for adult schizophre-
nia in the British 1946 birth cohort. 
Lancet 344, 1398–1402.
Kalus, P., Buri, C., Slotboom, J., Gralla, J., 
Remonda, L., Dierks, T., Strik, W.K., 
Shroth, G., and Kiefer, C. (2004). 
Volumetry and diffusion tensor 
imaging of hippocampal suregions 
der Linden, J. A., Schothorst, P. F., 
van Engeland, H., and Kahn, R. S. 
(2002). Brain volume changes in 
ﬁ  rst-  episode schizophrenia: a 1-year 
follow-up study. Arch. Gen. Psychiatry 
59, 1002–1010.
Cannon, T. D., Bearden, C. E., Hollister, 
J. M., Rosso, I. M., Sanchez, L. E., and 
Hadley, T. (2000). Childhood cogni-
tive functioning in schizophrenia 
patients and their unaffected siblings: 
a prospective cohort study. Schizophr. 
Bull. 26, 379–393.
Caspi, A., Reichenberg, A., Weiser, 
M., Rabinowitz, J., Kaplan, Z., 
Knobler, H., Davidson-Sagi, N., and 
Davidson, M. (2003). Cognitive per-
formance in schizophrenia patients 
assessed before and following the ﬁ  rst 
psychotic episode. Schizophr. Res. 65, 
87–94.
Chakos, M. H., Schobel, S. A., Gu, H., 
Gerig, G., Bradford, D., Charles, C., 
and Lieberman, J. A. (2005). Duration 
of illness and treatment effects on hip-
pocampal volume in male patients 
with schizophrenia. Br. J. Psychiatry 
186, 26–31.
Cornblatt, B., Obuchowski, M., Roberts, 
S., Pollack, S., and Erlenmeyer-
Kimling, L. (1999). Cognitive and 
behavioral precursors of schizophre-
nia. Dev. Psychopathol. 11, 487–508.
DeLisi, L. E., Sakuma, M., Ge, S., and 
Kushner, M. (1998). Association of 
brain structural change with the 
heterogeneous course of schizophre-
nia from early childhood through 
five years subsequent to a first 
 hospitalization.  Psychiatry. Res. 84, 
75–88.
Fuller, R., Nopoulos, P., Arndt, S., O’Leary, 
D., Ho, B. C., and Andreasen, N. C. 
(2002). Longitudinal assessment of 
premorbid cognitive functioning in 
patients with schizophrenia through 
examination of standardized scholas-
tic test performance. Am. J. Psychiatry 
159, 1183–1189.
Gschwandtner, U., Aston, J., Borgwardt, S., 
Drewe, M., Feinendegen, C., Lacher, D., 
Lanzarone, A., Stieglitz, R. D., Riecher-
Rössler, A., and Basel Early Detection 
of Psychosis Study – Früherkennung 
von Psychosen (FEPSY). (2003). 
Neuropsychological and neurophysi-
ological findings in individuals sus-
pected to be at risk for schizophrenia: 
preliminary results from the Basel 
early detection of psychosis study – 
Fruherkennung von Psychosen 
(FEPSY). Acta Psychiatr. Scand. 108, 
152–155.
Gur, R. E., Cowell, P., Turetsky, B. I., 
Gallacher, F., Cannon, T., Bilker, W., 
and Gur, R. C. (1998). A follow-up 
magnetic resonance imaging study of 
schizophrenia. Relationship of neu-
roanatomical changes to clinical and Frontiers in Human Neuroscience  www.frontiersin.org  October 2009  | Volume 3  |  Article 36  |  6
Rund  Is schizophrenia a neurodegenerative disorder?
Citation: Rund BR (2009) Is there 
a degenerative process going on in 
the brain of people with schizophre-
nia?. Front. Hum. Neurosci. 3:36. doi: 
10.3389/neuro.09.036.2009
Copyright © 2009 Rund. This is an open-
access article subject to an exclusive license 
agreement between the authors and the 
Frontiers Research Foundation, which 
permits unrestricted use, distribution, and 
reproduction in any medium, provided the 
original authors and source are credited.
mechanism. Am. J. Psychiatry 155, 
1661–1670.
Conflict of Interest Statement: The 
authors declare that the research was con-
ducted in the absence of any commercial or 
ﬁ  nancial relationships that could be con-
strued as a potential conﬂ  ict of interest.
Received: 14 June 2009; paper pending pub-
lished: 05 August 2009; accepted: 05 October 
2009; published online: 26 October 2009.
morphometry study. Neuroimage 32, 
511–519.
Wood, S. J., Pantelis, C., Proffitt, T., 
Phillips, L. J., Stuart, G. W., Buchanan, 
J. A., Mahony, K., Brewer, W., Smith, D. 
J., and McGorry, P. D. (2003). Spatial 
working memory ability is a marker 
of risk-for-psychosis. Psychol. Med. 33, 
1239–1247.
Woods, B. T. (1998). Is schizophrenia a 
progressive neurodevelopmental dis-
order? Toward a unitary pathogenetic 
Weinberger, R. D., and Marenco, S. (2003). 
Schizophrenia as a  neurodevelopmental 
disorder. In Schizophrenia, 2nd Edn., 
S. R. Hirsch and D. R. Weinberger, eds 
(London, Blackwell Publishing), pp. 
326–348.
Whitford, T. J., Grieve, S. M., Farrow, T. F., 
Gomes, L., Brennan, J., Harris, A. W., 
Gordon, E., and Williams, L. M. (2006). 
Progressive grey matter atrophy over 
the ﬁ  rst 2–3 years of illness in ﬁ  rst-
episode schizophrenia: a tensor-based 